Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
New device may straighten bent fingers without surgery
Disease control CompletedThis study tested a device called MiniFlo that slowly stretches bent fingers back into place in people with advanced Dupuytren's disease. 18 adults with stage III-IV disease used the device. Researchers measured how much finger straightening improved and checked for pain or side …
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New lens offers hope for clearer vision in cataract patients with keratoconus
Disease control CompletedThis study tested a special intraocular lens (Vivity EDOF) in 10 adults who had cataracts and mild keratoconus, a condition that thins and bulges the cornea. All participants received the lens in both eyes during standard cataract surgery. The goal was to see if the lens could pr…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Morning espresso may Kick-Start digestion after pancreatic surgery
Symptom relief CompletedThis trial investigates whether drinking coffee after pancreatic surgery can help the bowel start working again sooner. About 200 adults who had open pancreatic surgery will receive either regular coffee, decaf coffee, or water twice a day. The main goal is to see how quickly the…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New lens combo may cut annoying halos after cataract surgery
Symptom relief CompletedThis study tested two different lens approaches for cataract surgery: one group got two different extended-depth-of-focus lenses (one in each eye), and the other got the same trifocal lens in both eyes. The goal was to see which caused fewer halos and better vision. 36 adults hav…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Bladder cancer drugs under the microscope: do they work in everyday practice?
Knowledge-focused CompletedThis observational study followed 35 adults with advanced urothelial (bladder) cancer who had stable disease after initial chemotherapy. They received either Avelumab as first-line maintenance therapy or Pembrolizumab as second-line therapy. Researchers tracked how long the cance…
Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC